Skip to content

Clinical trials

Shock, Cardiogenic trials in Germany with no applicable phase

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Shock, Cardiogenic Phase: Not applicable Country / region: Germany Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20121
20141
20161
20192
20211
20221
20231
20251
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed5
Not yet recruiting3
Terminated2
Unknown status2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Leipzig Heart Science gGmbH2
University of Leipzig2
Abbott Medical Devices1
Abiomed Inc.1
Christian Schulze1
Helios Health Institute GmbH1
Martin-Luther-Universität Halle-Wittenberg1
University of Leicester1
Universitätsklinikum Hamburg-Eppendorf1
Xenios AG1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Shock, Cardiogenic12
Myocardial Infarction3
Heart Failure2
Acute Coronary Syndrome1
Cardiovascular Diseases1
Inflammation1
Multiple Organ Failure1
ST Elevation Myocardial Infarction1
Systemic Inflammatory Response Syndrome1

Trials

Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.